JPS4921149B1 - - Google Patents
Info
- Publication number
- JPS4921149B1 JPS4921149B1 JP12761070A JP12761070A JPS4921149B1 JP S4921149 B1 JPS4921149 B1 JP S4921149B1 JP 12761070 A JP12761070 A JP 12761070A JP 12761070 A JP12761070 A JP 12761070A JP S4921149 B1 JPS4921149 B1 JP S4921149B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12761070A JPS4921149B1 (zh) | 1970-12-28 | 1970-12-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12761070A JPS4921149B1 (zh) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4921149B1 true JPS4921149B1 (zh) | 1974-05-30 |
Family
ID=14964329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12761070A Pending JPS4921149B1 (zh) | 1970-12-28 | 1970-12-28 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4921149B1 (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011079846A (ja) * | 2002-11-21 | 2011-04-21 | Novartis Vaccines & Diagnostics Inc | ホスホチジルイノシトール（ｐｉ）３−キナーゼインヒビターとしての２，４，６−三置換ピリミジン、および癌の処置におけるその使用 |
| US8865894B2 (en) | 2012-02-24 | 2014-10-21 | Novartis Ag | Oxazolidin-2-one compounds and uses thereof |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| US9434719B2 (en) | 2013-03-14 | 2016-09-06 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
-
1970
- 1970-12-28 JP JP12761070A patent/JPS4921149B1/ja active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011079846A (ja) * | 2002-11-21 | 2011-04-21 | Novartis Vaccines & Diagnostics Inc | ホスホチジルイノシトール（ｐｉ）３−キナーゼインヒビターとしての２，４，６−三置換ピリミジン、および癌の処置におけるその使用 |
| US8865894B2 (en) | 2012-02-24 | 2014-10-21 | Novartis Ag | Oxazolidin-2-one compounds and uses thereof |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| US10202371B2 (en) | 2012-11-12 | 2019-02-12 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors |
| US9434719B2 (en) | 2013-03-14 | 2016-09-06 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US9688672B2 (en) | 2013-03-14 | 2017-06-27 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US10112931B2 (en) | 2013-03-14 | 2018-10-30 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |